Upper gastrointestinal acute graft-versus-host disease adds minimal prognostic value in isolation or with other graft-versus-host disease symptoms as currently diagnosed and treated

Upper gastrointestinal acute graft-versus-host disease is reported in approximately 30% of hematopoietic stem cell transplant recipients developing acute graft-versus-host disease. Currently classified as Grade II in consensus criteria, upper gastrointestinal acute graft-versus-host disease is often...

Descripción completa

Detalles Bibliográficos
Autores principales: Nikiforow, Sarah, Wang, Tao, Hemmer, Michael, Spellman, Stephen, Akpek, Görgün, Antin, Joseph H., Choi, Sung Won, Inamoto, Yoshihiro, Khoury, Hanna J., MacMillan, Margaret, Marks, David I., Meehan, Ken, Nakasone, Hideki, Nishihori, Taiga, Olsson, Richard, Paczesny, Sophie, Przepiorka, Donna, Reddy, Vijay, Reshef, Ran, Schoemans, Hélène, Waller, Ned, Weisdorf, Daniel, Wirk, Baldeep, Horowitz, Mary, Alousi, Amin, Couriel, Daniel, Pidala, Joseph, Arora, Mukta, Cutler, Corey
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ferrata Storti Foundation 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6165812/
https://www.ncbi.nlm.nih.gov/pubmed/30076185
http://dx.doi.org/10.3324/haematol.2017.182550

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6165812/
https://www.ncbi.nlm.nih.gov/pubmed/30076185
http://dx.doi.org/10.3324/haematol.2017.182550

Ejemplares similares